Molecular Computing Patent Application Trends 2025

1 Molecular Computing Patent Application Filing Activity
2 Molecular Computing patent applications in 2025
3 Top Technology Areas in Molecular Computing
- 3.1 Top CPC Codes
4 Top Companies in Molecular Computing 2025
5 New Companies in Molecular Computing (Last Month)
6 Emerging Technology Areas in Molecular Computing
7 Top Companies in Emerging Molecular Computing Technologies 2025
8 Top Inventors in Molecular Computing
9 Top Collaborations in Molecular Computing
10 Top US States for Molecular Computing Inventors
11 Top Cities for Molecular Computing Inventors

Molecular Computing Patent Application Filing Activity

Molecular Computing patent applications in 2025

Top Technology Areas in Molecular Computing

Top CPC Codes

A61K39/4611 (No explanation available)
- Count: 5 patents
- Example: 20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)
A61K39/4631 (No explanation available)
- Count: 5 patents
- Example: 20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)
C07K14/7051 (No explanation available)
- Count: 3 patents
- Example: 20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)
A61P35/00 (No explanation available)
- Count: 3 patents
- Example: 20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)
A61K2239/31 (No explanation available)
- Count: 2 patents
- Example: 20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)
A61K2239/38 (No explanation available)
- Count: 2 patents
- Example: 20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)
A61K39/464412 (No explanation available)
- Count: 2 patents
- Example: 20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)
C07K2317/92 (No explanation available)
- Count: 2 patents
- Example: 20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)
C07K2319/02 (No explanation available)
- Count: 2 patents
- Example: 20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)
C07K2319/03 (No explanation available)
- Count: 2 patents
- Example: 20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)

Top Companies in Molecular Computing 2025

800px

The Regents of the University of California

Number of Molecular Computing patents: 2
Top CPC codes:
- A61K39/4611 (No explanation available): 2 patents
- A61K39/4631 (No explanation available): 2 patents
- C07K14/7051 (No explanation available): 1 patents
Recent patents:
- 20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California) (20250130)
- 20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California) (20250130)

INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.

Number of Molecular Computing patents: 1
Top CPC codes:
- A61K39/464402 (No explanation available): 1 patents
- A61K39/4611 (No explanation available): 1 patents
- A61K39/4631 (No explanation available): 1 patents
Recent patents:
- 20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.) (20250206)

Molecular Partners AG

Number of Molecular Computing patents: 1
Top CPC codes:
- C07K14/47 (No explanation available): 1 patents
- A61K45/06 (No explanation available): 1 patents
- A61K38/00 (No explanation available): 1 patents
Recent patents:
- 20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG) (20250206)

THE GENERAL HOSPITAL CORPORATION

Number of Molecular Computing patents: 1
Top CPC codes:
- C07K14/4702 (No explanation available): 1 patents
- A61K39/4611 (No explanation available): 1 patents
- A61K39/4631 (No explanation available): 1 patents
Recent patents:
- 20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION) (20250306)

PRECIGEN, INC.

Number of Molecular Computing patents: 1
Top CPC codes:
- C12N15/52 (No explanation available): 1 patents
- C12N1/20 (No explanation available): 1 patents
- C12N9/0006 (No explanation available): 1 patents
Recent patents:
- 20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.) (20250123)